JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB264727

Human FZD2 (Frizzled 2) knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

FZD2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1.

View Alternative Names

FZD2_HUMAN, Frizzled homolog 2, Frizzled-2, Fz-2, FzE 2, Mfz10, hFz 2

1 Images
Sanger Sequencing - Human FZD2 (Frizzled 2) knockout HeLa cell line (AB264727)
  • Sanger seq

Unknown

Sanger Sequencing - Human FZD2 (Frizzled 2) knockout HeLa cell line (AB264727)

Homozygous : 1 bp insertion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264727-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264727 Human FZD2 (Frizzled 2) knockout HeLa cell line", "number":"AB264727-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264727-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264727 Human FZD2 (Frizzled 2) knockout HeLa cell line", "number":"AB264727-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
FZD2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Frizzled 2 (FZD2) is a member of the Frizzled receptor family which plays a role in the Wnt signaling pathway. FZD2 also known by alternate names like FzE2 and HFzd2r is a membrane-bound receptor with a mass of approximately 70 kDa. This protein is expressed in various tissues including the brain heart and lungs indicating its involvement in multiple cellular processes. The receptor contains a distinct structure comprising seven transmembrane domains which facilitates its interaction with other molecules and downstream signaling components.
Biological function summary

FZD2 acts as a critical mediator within the Wnt signaling pathway and it often functions as part of the Frizzled receptor complex. This protein binds to secreted Wnt ligands initiating intracellular signaling cascades that regulate cell fate proliferation and differentiation. Through these interactions FZD2 influences embryonic development and tissue homeostasis. The receptor's role in these fundamental processes highlights its importance in maintaining proper cellular and organismal function.

Pathways

FZD2 participates in the canonical Wnt/β-catenin and non-canonical Wnt signaling pathways. In the canonical pathway FZD2 assists in the stabilization and accumulation of β-catenin in the cytoplasm which ultimately translocates to the nucleus to regulate gene expression. In the non-canonical pathway FZD2 plays a part in the planar cell polarity and Wnt/Ca2+ pathways. Proteins like Dishevelled (DVL) and LRP5/6 are closely related to FZD2 facilitating its role in diverse signaling events important for development and cellular dynamics.

FZD2's involvement in the Wnt signaling pathway associates it with conditions like cancer and osteoporosis. Aberrant FZD2 signaling can contribute to tumorigenesis since alterations in Wnt pathways often lead to uncontrolled cell division and cancer progression. Similarly defects in Wnt-mediated bone formation can link FZD2 to osteoporosis. In these contexts FZD2 interacts with proteins such as β-catenin and Dkk1 which help mediate its effects on disease pathogenesis and progression.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com